Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Feb 24.
Published in final edited form as: J Am Coll Nutr. 2015 Nov 23;35(3):217–223. doi: 10.1080/07315724.2014.971193

Ready-to-Eat Cereal Consumption with Total and Cause-Specific Mortality: Prospective Analysis of 367,442 Individuals

Min Xu 1, Tao Huang 1, Albert W Lee 1, Lu Qi 1, Susan Cho 1
PMCID: PMC5325722  NIHMSID: NIHMS846020  PMID: 26595440

Abstract

Background

Intakes of ready-to-eat cereal (RTEC) have been inversely associated with risk factors of chronic diseases such as cardiovascular disease (CVD), type 2 diabetes, and certain cancers; however, their relations with total and cause-specific mortality remain unclear.

Objective

To prospectively assess the associations of RTEC intakes with all causes and disease-specific mortality risk.

Design

The study included 367,442 participants from the prospective National Institutes of Health (NIH)–AARP Diet and Health Study. Intakes of RTEC were assessed at baseline.

Results

Over an average of 14 years of follow-up, 46,067 deaths were documented. Consumption of RTEC was significantly associated with reduced risk of mortality from all-cause mortality and death from CVD, diabetes, all cancer, and digestive cancer (all p for trend < 0.05). In multivariate models, compared to nonconsumers of RTEC, those in the highest intake of RTEC had a 15% lower risk of all-cause mortality and 10%–30% lower risk of disease-specific mortality. Within RTEC consumers, total fiber intakes were associated with reduced risk of mortality from all-cause mortality and deaths from CVD, all cancer, digestive cancer, and respiratory disease (all p for trend < 0.005).

Conclusions

Consumption of RTEC was associated with reduced risk of all-cause mortality and mortality from specific diseases such as CVD, diabetes, and cancer. This association may be mediated via greater fiber intake.

Keywords: ready-to-eat cereals, fiber, CVD, mortality

INTRODUCTION

Ready-to-eat cereals (RTECs) are major sources of dietary fiber (mainly cereal fiber) and other nutrients, such as minerals and antioxidants [1, 2], which have shown beneficial effects on human health, such as improvement of weight loss and lipid profile, as well as inhibition of systemic inflammation [36]. In epidemiology studies, consumption of RTEC or cereal fiber has been associated with reduced levels of a variety of risk factors for cardiovascular disease (CVD), type 2 diabetes, and certain cancers [4, 712]. In addition, breakfast cereal intake has been associated with reduced mortality in American males [13]. In our recent analyses, we found that intake of cereal fiber (fiber from grains) was inversely related to all-cause mortality and death from cancer, CVD, infectious disease, and respiratory disease in the study cohort (L.Q. et al., http://www.biomedcentral.com/1741-7015/13/59). However, few studies have comprehensively assessed the associations between RTEC intake and total or cause-specific mortality, especially in large prospective cohorts.

In the present study, we used data from a large-scale cohort, the National Institutes of Health (NIH)–AARP Diet and Health Study (ClinicalTrials.gov number, NCT00340015) and prospectively examined the associations of RTEC intakes with risk of all-cause mortality and mortality from CVD, type 2 diabetes, cancers, and other chronic diseases in U.S. men and women. We also analyzed the associations between RTEC intakes and mortality according to fiber intakes in RTEC consumers.

METHODS

Study Population

The NIH–AARP Diet and Health Study included 566,399 AARP members aged 50 to 71 years from 6 U.S. states (California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania) and 2 metropolitan areas (Atlanta, Georgia, and Detroit, Michigan). Participants responded to questionnaires mailed in October 1995 and December 1997. Details of the NIH–AARP Study have been previously described [14]. Among participants who returned the questionnaires with satisfactory dietary data, we excluded individuals who indicated that they were proxies for the intended respondent (n = 15,760) as well as those who had cancer (n = 50,591), heart disease (n = 80,254), stroke (n = 12,812), diabetes (n = 52,647), or self-reported end-stage renal disease at baseline (n = 1,299). We also excluded those who reported extreme consumption (>2 times the interquartile ranges of Box-Cox transformed intake) of total energy (n = 3771) and dietary fiber (n = 3324). After exclusions (n = 198,957), the analytic cohort included 367,442 individuals. The NIH–AARP Diet and Health study was approved by the Special Studies Institutional Review Board of the U.S. National Cancer Institute.

Assessment of Exposure

At baseline, dietary intakes were assessed with a self-administered 124-item food frequency questionnaire, which was an early version of the Diet History Questionnaire developed at the National Cancer Institute [15]. Participants were asked to report their usual frequency of intake and portion size over the past 12 months using 10 predefined frequency categories ranging from never to 6+ times per day for beverages and from never to 2+ times per day for solid foods with 3 categories of portion size. The food items, portion sizes, and nutrient database were constructed using the U.S. Department of Agriculture’s 1994–1996 Continuing Survey of Food Intakes by Individuals [16].

The nutrient database for dietary fiber was based on AOAC method 991.43 [17]. In specifying numbers of deaths by intake quartile, the number of deaths is determined by the energy-adjusted intake quartile for the entire population; when deaths are specific to a sex, we used the quartiles within the sex. We also collected demographic, anthropometric, and lifestyle information, including history of smoking, physical activity, family history of cancers, menopausal hormone therapy use in women, and some medical conditions at baseline.

The performance of the food frequency questionnaire was evaluated by using 2 nonconsecutive 24-hour recalls among a subgroup of the cohort consisting of 2053 persons. According to evaluation on 26 nutrients, when adjusted for reported energy intake, performance improved; estimated correlations with true intake ranged from 0.36 to 0.76 [18].

Ascertaining Mortality

The AARP data set denotes date of death (dod) and cause of death (cod). There are 22 broad categories for cod. Subcategories, such as digestive system, female breast, and prostate cancer, can be identified by underlying International Classification of Diseases (ICD) codes. The dod field is completed through 2009, with some dods entered after 2009. The cod field is complete through 2008, with some cods entered after 2008. Most cod and dod values were not entered simultaneously after 2008. Some cod values are missing for dods in 2008 or earlier. The modeling analysis for specific causes of death is done with the study end date of 2008. For total mortality, we did models for study end dates in 2008 and 2009. Subjects with dod after the study’s end date are treated as alive at the end of the study, with no death or cause of death in the model. When the study end date is 2008 and there is a dod but no cod for 2008 or earlier, the subject is not included in the modeling for cod but only total mortality. Thus, when specifying numbers of deaths it depends on both the study end date and whether the cod field is missing.

We determined vital status through a periodic linkage of the cohort to the Social Security Administration Death Master File and follow-up searches of the National Death Index Plus for participants who matched the Social Security Administration Death Master File, cancer registry linkage, questionnaire responses, and responses to other mailings. We used the International Classification of Diseases, Ninth Revision, and the International Statistical Classification of Diseases, 10th Revision to define death as follows: cancer (ICD-9, 140–239; ICD-10, C00–C97 and D00–D48), heart disease (ICD-9, 390–398, 401–404, 410–429, and 440–448; ICD-10, I00–I13, I20–I51, and I70–I78), stroke (ICD-9, 430–438; ICD-10, I60–I69), infections (ICD-9, 001–139; ICD-10, A00–B99), diabetes (ICD-9, 250; ICD-10, E10–E14), respiratory disease (ICD-9, 480–487 and 490–496; ICD-10, J10–J18 and J40–J47), and all other causes. CVD death included death from heart disease and stroke.

Statistical Analysis

We used the Cox proportional hazards model to estimate hazard ratios (HRs) and 2-sided 95% confidence intervals (CIs) using the SAS PROC PHREG procedure (Version 9.1; SAS Institute Inc., Cary, NC). Person-years of follow-up were calculated from the date of the baseline questionnaire until the date of death or the end of follow-up (December 31, 2009), whichever occurred first. We evaluated the proportional hazards assumption and confirmed it by modeling interaction terms consisting of the cross product of time and dietary RTEC intake. Because there was no statistically significant interaction by sex (p > 0.05), we primarily reported data from the combined cohort. Intakes of RTEC and fiber were adjusted for total energy intake using the residual method [16] and were categorized into quartiles. We estimated the HRs for quartiles of dietary RTEC or fiber intake. We presented an age-adjusted model and 2 multivariate models. Multivariate model 1 was adjusted for age, gender, smoking status, smoking dose, and time since quitting smoking. In multivariate model 2, we also adjusted for race/ethnicity, education, marital status, self-rated health status, body mass index, physical activity, use of menopausal hormone therapy, and intake of alcohol, red meat, fruits, vegetables, and total energy. For missing data in each covariate, we created indicator variables. Generally, missing data was less than 5%. The model results summary includes the results of statistical tests for trend in the response for the risk variable. Quartiles trend p denotes the p value when the median value within the risk variable quartile is included in the hazard model as linear.

RESULTS

Table 1 shows baseline characteristics of study participants (N = 367,442). During an average of 14 years of follow-up (total person-years, 5,148,760), we documented 46,067 deaths, among which 11,283 were from CVD; 19,043 were from cancer, 371 were from diabetes, 3796 were from respiratory disease, 922 were from infection, and 5223 were from other causes. At baseline, intakes of RTEC were inversely correlated with prevalence of overweight, obesity, and current smoking as well as intake of red meat. The levels of moderate and vigorous physical activity were higher among participants with higher intakes of RTEC than those with lower intakes.

Table 1.

Baseline Clinical Characteristics of the Participants

RTEC Consumers
Total Population Nonconsumer of RTEC Q1 Q2 Q3 Q4
Subjects 367,442 51,352 79,022 79,023 79,022 79,023
Age (mean years) 61.66 61.60 60.98 61.49 62.01 62.23
Male (%) 56.13 57.80 51.97 54.67 56.10 60.70
Race
   White (%) 92.94 89.72 90.22 92.76 94.64 96.18
   Black (%) 3.59 4.64 5.30 3.83 2.78 1.77
   Other (%) 3.48 5.64 4.48 3.41 2.58 2.04
Education
   <High school (%) 5.35 6.16 6.21 5.57 4.92 4.20
   High school grad (%) 29.86 29.87 31.18 30.57 29.74 27.95
   Some college (%) 23.80 24.21 25.15 24.65 23.58 21.58
   College grad (%) 40.98 39.75 37.45 39.21 41.76 46.28
   Married (%) 68.09 64.50 65.84 68.18 69.80 70.87
   Physical activity low (%) 31.04 34.70 36.15 31.57 27.57 26.54
   1–2 Times/week (%) 22.47 20.94 22.57 23.67 22.83 21.81
   3–4 Times/week (%) 27.30 24.35 24.29 27.32 29.55 29.94
   ≥5 Times/week (%) 19.18 20.02 16.99 17.44 20.05 21.70
BMI
   <18.5 (%) 1.10 1.57 1.14 0.97 0.95 1.04
   18.5–25 (%) 36.95 39.47 34.94 33.77 36.70 40.77
   25–30 (%) 42.37 41.15 41.38 42.60 43.35 42.92
   ≥30 (%) 19.58 17.81 22.54 22.66 19.00 15.26
Health status
   Excellent (%) 21.21 22.41 19.85 19.55 21.08 23.58
   Very good (%) 40.17 38.29 38.94 40.07 41.36 41.55
   Good (%) 31.74 31.59 33.20 33.19 31.22 29.43
   Fair (%) 6.23 6.94 7.24 6.50 5.75 4.96
   Poor (%) 0.65 0.77 0.77 0.69 0.59 0.48
   Energy intake (kcal/d) 1805.56 1745.07 1860.51 1879.43 1893.74 1627.85
   Alcohol intake (g/d) 14.74 20.83 18.52 14.42 13.06 8.99
   Red meat intake (oz/d) 1.99 2.08 2.21 2.15 2.00 1.52
   Total fruit intake (cup eq/d) 1.99 1.89 1.87 2.02 2.16 2.00
   Total vegetable intake (cup eq/d) 1.92 1.94 1.97 2.00 2.00 1.69

RTEC = ready-to-eat cereal, BMI = body mass index.

RTEC Intake with Total Mortality

In age-adjusted analysis, we found that intake of RTEC was inversely associated with all-cause mortality (p for trend < 0.0001; Table 2). Compared to nonconsumers of RTEC, the HRs (95% CI) across increasing quartiles of RTEC intake were 0.94 (0.91–0.97), 0.85 (0.82–0.87), 0.75 (0.72–0.77), and 0.67 (0.65–0.69). Further adjustment for gender and smoking status and time since quitting smoking (model 1) did not appreciably change the results. In multivariate analysis (model 2) with additional adjustment for race/ethnicity, education, marital status, self-rated health status, obesity (underweight, overweight, and obesity), physical activity, use of menopausal hormone therapy, and intake of alcohol, red meat, fruits, vegetables, and total energy (model 2), the HRs (95% CIs) across increasing quartiles of RTEC were 0.94 (0.92–0.97), 0.92 (0.89–0.95), 0.88 (0.86–0.91), and 0.85 (0.83–0.88) compared to nonconsumers (p for trend < 0.0001). Within RTEC consumers, total fiber intake was significantly related to reduced risk of total mortality (multivariate- adjusted p for trend < 0.0001). Compared to the lowest quartile, total mortality was reduced by 14% in the highest consumers of total fiber (Table 3).

Table 2.

Hazard Ratios of Mortality According to Intakes of RTECa

RTEC Consumers
Nonconsumers of RTEC Q1 Q2 Q3 Q4 p Trend
RTEC (g/d) 0.0 0.67 3.48 9.33 22.48
All-cause mortality
   No. of deaths 7686 10,394 9965 9318 8704
   Age adjusted 1.00 0.94 (0.91, 0.97) 0.85 (0.82, 0.87) 0.75 (0.72, 0.77) 0.67 (0.65, 0.69) <0.0001
   Model 1 1.00 0.94 (0.91, 0.97) 0.90 (0.87, 0.93) 0.84 (0.82, 0.87) 0.80 (0.77, 0.82) <0.0001
   Model 2 1.00 0.94 (0.92, 0.97) 0.92 (0.89, 0.95) 0.88 (0.86, 0.91) 0.85 (0.83, 0.88) <0.0001
CVD mortality
   No. of deaths 1960 2488 2492 2328 2015 <0.0001
   Age adjusted 1.00 0.90 (0.85, 0.96) 0.84 (0.79, 0.89) 0.73 (0.68, 0.77) 0.60 (0.56, 0.63) <0.0001
   Model 1 1.00 0.90 (0.85, 0.95) 0.88 (0.83, 0.94) 0.81 (0.76, 0.86) 0.70 (0.66, 0.75) <0.0001
   Model 2 1.00 0.90 (0.85,0.95) 0.90 (0.85, 0.95) 0.86 (0.81, 0.91) 0.76 (0.71, 0.81) <0.0001
Diabetes mortality
   No. of deaths 113 79 100 75 50
   Age adjusted 1.00 0.98 (0.70, 1.38) 1.16 (0.84, 1.61) 0.95 (0.68, 1.32) 0.52 (0.36, 0.77) <0.0001
   Model 1 1.00 0.98 (0.69, 1.37) 1.20 (0.87, 1.67) 1.01(0.72, 1.42) 0.58 (0.39, 0.85) <0.001
   Model 2 1.00 0.96 (0.68, 1.36) 1.22 (0.87, 1.69) 1.14 (0.81, 1.61) 0.70 (0.47, 1.03) <0.05
All cancer mortality
   No. of deaths 3043 4393 4105 3863 3639
   Age adjusted 1.00 0.99 (0.95, 1.04) 0.88 (0.84, 0.92) 0.79 (0.75, 0.82) 0.71 (0.68, 0.75) <0.0001
   Model 1 1.00 0.99 (0.94, 1.04) 0.94 (0.90, 0.99) 0.90 (0.86, 0.94) 0.86 (0.82, 0.91) <0.0001
   Model 2 1.00 0.98 (0.94, 1.03) 0.95 (0.90, 0.99) 0.92 (0.88, 0.97) 0.90 (0.86, 0.95) <0.0001
Digestive cancer mortality
   No. of deaths 721 1035 1037 982 895
   Age adjusted 1.00 1.00 (0.91, 1.10) 0.94 (0.86, 1.04) 0.84 (0.77, 0.93) 0.73 (0.67, 0.81) <0.0001
   Model 1 1.00 1.00 (0.91, 1.10) 0.97 (0.89, 1.07) 0.90 (0.82, 0.99) 0.81 (0.73, 0.89) <0.0001
   Model 2 1.00 1.00 (0.91, 1.10) 1.00 (0.91, 1.10) 0.95 (0.86, 1.05) 0.87 (0.79, 0.97) <0.001
Respiratory disease mortality
   No. of deaths 1114 1539 1343 1161 1026
   Age adjusted 1.00 0.95 (0.88, 1.03) 0.79 (0.73, 0.85) 0.64 (0.59, 0.70) 0.55 (0.50, 0.60) <0.0001
   Model 1 1.00 0.94 (0.87, 1.02) 0.90 (0.84, 0.98) 0.87 (0.80, 0.94) 0.74 (0.67, 0.82) <0.0001
   Model 2 1.00 0.95 (0.88, 1.03) 0.94 (0.87, 1.02) 0.91 (0.84, 0.99) 0.91 (0.83, 0.99) 0.06
Infectious disease
   No. of deaths 56 79 100 86 197
   Age adjusted 1.00 0.96 (0.78, 1.18) 0.78 (0.63, 0.97) 0.71 (0.57, 0.88) 0.76 (0.62, 0.94) <0.01
   Model 1 1.00 0.95 (0.77, 1.17) 0.81 (0.66, 1.01) 0.77 (0.62, 0.96) 0.86 (0.70, 1.07) NS
   Model 2 1.00 0.97 (0.79, 1.20) 0.85 (0.68, 1.06) 0.84 (0.68, 1.05) 0.97 (0.78, 1.21) NS

RTEC = ready-to-eat cereal, CVD = cardiovascular disease.

a

Multivariate model 1: adjusted for age, gender, smoking status, smoking dose, and time since quitting smoking. Multivariate model 2, adjusted for covariates in model 1 and race/ethnicity, education, marital status, self-rated health status, body mass index, physical activity, use of menopausal hormone therapy, and intake of alcohol, red meat, fruits, vegetables, and total energy.

Table 3.

Hazard Ratios of Mortality According to Fiber Intake (in Quartiles) within RTEC Consumersa

Q1 Q2 Q3 Q4 p
Fiber intake (g/d) 9.54 15.50 19.1 26.2
All-cause mortality
   No. of deaths 12,428 9676 8368 7909
   Age adjusted 1.00 0.74 (0.72, 0.76) 0.62 (0.61, 0.64) 0.58 (0.56, 0.59) <0.0001
   Model 1 1.00 0.88 (0.86, 0.90) 0.80 (0.78, 0.82) 0.78 (0.76, 0.80) <0.0001
   Model 2 1.00 0.93 (0.91, 0.96) 0.88 (0.85, 0.91) 0.86 (0.82, 0.89) <0.0001
CVD mortality
   No. of deaths 3007 2379 2032 1905
   Age adjusted 1.00 0.76 (0.72, 0.80) 0.63 (0.60, 0.67) 0.75 (0.72, 0.77) <0.0001
   Model 1 1.00 0.89 (0.84, 0.94) 0.80 (0.75, 0.85) 0.84 (0.82, 0.87) <0.0001
   Model 2 1.00 0.95 (0.89, 1.01) 0.87 (0.82, 0.94) 0.88 (0.86, 0.91) <0.0001
Diabetes mortality
   No. of deaths 103 91 58 63
   Age adjusted 1.00 0.86 (0.65, 1.14) 0.54 (0.39, 0.87) 0.57 (0.41, 0.78) <0.0001
   Model 1 1.00 0.94 (0.70, 1.25) 0.61 (0.44, 0.85) 0.66 (0.48, 0.92) <0.01
   Model 2 1.00 1.04 (0.76, 1.43) 0.74 (0.51, 1.09) 0.87 (0.56, 1.35) NS
All cancer mortality
   No. of deaths 5167 3982 3513 3338
   Age adjusted 1.00 0.74 (0.71, 0.77) 0.64 (0.61, 0.66) 0.59 (0.57, 0.62) <0.0001
   Model 1 1.00 0.89 (0.85, 0.93) 0.84 (0.80, 0.88) 0.83 (0.79, 0.87) <0.0001
   Model 2 1.00 0.93 (0.89, 0.98) 0.90 (0.86, 0.95) 0.90 (0.85, 0.96) <0.005
Digestive cancer mortality
   No. of deaths 1197 992 880 880
   Age adjusted 1.00 0.82 (0.75, 0.89) 0.71 (0.65, 0.78) 0.70 (0.64, 0.77) <0.0001
   Model 1 1.00 0.89 (0.82, 0.97) 0.81 (0.74, 0.89) 0.82 (0.75, 0.90) <0.0001
   Model 2 1.00 0.91 (0.82, 0.99) 0.83 (0.75, 0.93) 0.83 (0.73, 0.94) <0.005
Respiratory disease mortality
   No. of deaths 2026 1295 931 817
   Age adjusted 1.00 0.60 (0.56, 0.65) 0.42 (0.39, 0.45) 0.36 (0.33, 0.39) <0.0001
   Model 1 1.00 0.90 (0.84, 0.97) 0.78 (0.72, 0.84) 0.78 (0.72, 0.85) <0.0001
   Model 2 1.00 0.96 (0.89, 1.04) 0.87 (0.79, 0.95) 0.90 (0.80,1.01) <0.005
Infectious disease
   No. of deaths 250 191 176 152
   Age adjusted 1.00 0.71 (0.58, 0.85) 0.62 (0.51, 0.76) 0.53 (0.43, 0.65) <0.0001
   Model 1 1.00 0.80 (0.66, 0.96) 0.74 (0.61, 0.91) 0.65 (0.53, 0.81) <0.001
   Model 2 1.00 0.88 (0.71, 1.09) 0.87 (0.69, 1.10) 0.75 (0.57, 1.00) 0.05

RTEC = ready-to-eat cereal, CVD = cardiovascular disease.

a

Multivariate model 1: adjusted for age, gender, smoking status, smoking dose, and time since quitting smoking. Multivariate model 2, adjusted for covariates in model 1 and race/ethnicity, education, marital status, self-rated health status, body mass index, physical activity, use of menopausal hormone therapy, and intake of alcohol, red meat, fruits, vegetables, and total energy.

RTEC Intake with Cause-Specific Mortality

We next tested the associations for cause-specific mortalities. In multivariate-adjusted analyses (model 2), intakes of RTEC were inversely associated with risk of deaths from CVD, diabetes, all cancer, and digestive cancer (all p for trend < 0.05; Table 2). Compared to nonconsumers of RTEC, people in the highest quartile of RTEC intake had 10% (all cancer) to 30% (type 2 diabetes) reduced risk of mortality. Within RTEC consumers, consumption of total fiber was significantly associated with reduced risks of deaths from CVD, all cancer, digestive cancer, respiratory disease (all multivariate-adjusted p for trend < 0.005; Table 3).

DISCUSSION

In this large prospective cohort study of U.S. population, we found significant inverse associations between intakes of RTEC with risk of all-cause mortality and from CVD, type 2 diabetes, cancer, and respiratory and infectious disease. Compared to individuals with the lowest intake of RTEC, those in the highest intake group had a 15% lower risk of all-cause mortality and 10%–30% lower risk of disease-specific mortality. Breakfast cereal intake was inversely associated with total and CVD-specific mortality [13]. Previous reports also found that cereal fiber intake was related to all-cause and cause-specific mortality (cancer, CVD, respiratory and infectious disease) [10, 20]. This is the first time that consumption of RTEC, as a whole, has been demonstrated to be associated with lower risks of total mortality and deaths from CVD, diabetes, cancer, and other chronic diseases.

To the best of our knowledge, the present study included thus far the largest number of deaths in a prospective setting. Our findings are concordant with previously observed protective effects of RTEC intake on risk factors for CVD, diabetes, and certain cancers [2, 2124]. In several epidemiological studies, intake of RTEC has also been related to weight control [22, 25], which may be linked to lower risks of CVD, diabetes, and cancer. In a previous analysis among our study samples, we found that intake of cereal fiber (fiber from grains) was inversely related to all-cause mortality and death from cancer, CVD, infectious disease, and respiratory disease (L.Q. et al., http://www.biomedcentral.com/1741-7015/13/59). In the present study, we found that within RTEC consumers, high fiber intake showed more protective effects against total mortality and deaths from CVD, all cancer, digestive cancer, and respiratory disease. The data suggest contents of fiber in RTEC may play a key role in contributing to the observed protective effects.

Our study has several limitations that deserve mention. RTEC intakes were evaluated by self-report at a single time point. It is likely dietary habits might change during the 14 years of follow-up period, and such temporal patterns were not reflected in our analysis. However, the measurement errors might bias the associations toward null. Similar to other analyses in existing cohorts, confounding due to correlations between RTEC consumption and other lifestyle and social economic factors might influence the associations. However, we have carefully adjusted for the dietary, lifestyle, and social economic covariates in analyses, though we are aware that unmeasured variables might still affect our analyses. The presented analysis was not a preplanned goal of the cohort, which may increase the possibility that the results reflect type I error. Moreover, the observational nature of our study limits causality inference between intake of RTEC and mortality, and randomized controlled trials are needed to justify the causality.

In summary, data from our study indicate that intake of RTEC may reduce the risk of all-cause mortality and death from chronic diseases such as CVD, diabetes, and cancer. Within RTEC consumers, high fiber intake showed more protective effects against all-cause mortality and death from chronic diseases, suggesting that cereal fiber may play a role in RTEC actions. The findings lend support to recommendation of increased consumption of RTEC, in particular cereal fiber–rich RTEC, to prevent chronic disease and optimize human health.

Acknowledgments

We thank all of the participants in the NIH–AARP study. We also thank Dr. YiKyung Park at the National Cancer Institute for her guidance throughout the study and Dr. David Hasza for statistical assistance.

FUNDING

This study is funded by an unrestricted research fund from NutraSource. Dr. Qi was supported by grants from the National Heart, Lung, and Blood Institute (HL071981), the National Institute of Diabetes and Digestive and Kidney Diseases (DK091718), the Boston Obesity Nutrition Research Center (DK46200), and United States–Israel Binational Science Foundation Grant 2011036. Dr. Qi was a recipient of the American Heart Association Scientist Development Award (0730094N).

Footnotes

Clinical Trial Registration Information: ClinicalTrials.gov number NCT00340015.

Author Contributions

The authors’ responsibilities were as follows: S.C. and L.Q. designed the research; A.L., M.X., T.H., S.C., and L.Q conducted the research; S.C. and L.Q. analyzed data; L.Q. wrote the article; S.C. and A.L. provided materials; L.Q. had primary responsibility for the final content of the article; and all authors read and approved the final article.

Conflict of Interest

L. Qi declares funding from NutraSource. No other authors declare a conflict of interest.

REFERENCES

  • 1.Neacsu M, McMonagle J, Fletcher RJ, Scobbie L, Duncan GJ, Cantlay L, de Roos B, Duthie GG, Russell WR. Bound phytophenols from ready-to-eat cereals: comparison with other plant-based foods. Food Chem. 2013;141:2880–2886. doi: 10.1016/j.foodchem.2013.05.023. [DOI] [PubMed] [Google Scholar]
  • 2.Albertson AM, Wold AC, Joshi N. Ready-to-eat cereal consumption patterns: the relationship to nutrient intake, whole grain intake, and body mass index in an older American population. J Aging Res. 2012;2012:631310. doi: 10.1155/2012/631310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Qi L, Hu FB. Dietary glycemic load, whole grains, and systemic inflammation in diabetes: the epidemiological evidence. Curr Opin Lipidol. 2007;18:3–8. doi: 10.1097/MOL.0b013e328011c6e0. [DOI] [PubMed] [Google Scholar]
  • 4.Qi L, van Dam RM, Liu S, Franz M, Mantzoros C, Hu FB. Wholegrain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care. 2006;29:207–211. doi: 10.2337/diacare.29.02.06.dc05-1903. [DOI] [PubMed] [Google Scholar]
  • 5.Harland JI, Garton LE. Whole-grain intake as a marker of healthy body weight and adiposity. Public Health Nutr. 2008;11:554–563. doi: 10.1017/S1368980007001279. [DOI] [PubMed] [Google Scholar]
  • 6.Abreu S, Santos R, Moreira C, Santos PC, Mota J, Moreira P. Food consumption, physical activity and socio-economic status related to bmi, waist circumference and waist-to-height ratio in adolescents. Public Health Nutr. 2014;17:1834–1849. doi: 10.1017/S1368980013001948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Deshmukh-Taskar P, Nicklas TA, Radcliffe JD, O’Neil CE, Liu Y. The relationship of breakfast skipping and type of breakfast consumed with overweight/obesity, abdominal obesity, other cardio metabolic risk factors and the metabolic syndrome in young adults. The National Health and Nutrition Examination Survey (NHANES): 1999–2006. Public Health Nutr. 2013;16:2073–2082. doi: 10.1017/S1368980012004296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Balvin Frantzen L, Trevino RP, Echon RM, Garcia-Dominic O, DiMarco N. Association between frequency of ready-to-eat cereal consumption, nutrient intakes, and body mass index in fourth-to sixth-grade low-income minority children. J Acad Nutr Diet. 2013;113:511–519. doi: 10.1016/j.jand.2013.01.006. [DOI] [PubMed] [Google Scholar]
  • 9.Bazzano LA, Song Y, Bubes V, Good CK, Manson JE, Liu S. Dietary intake of whole and refined grain breakfast cereals and weight gain in men. Obes Res. 2005;13:1952–1960. doi: 10.1038/oby.2005.240. [DOI] [PubMed] [Google Scholar]
  • 10.Cho SS, Qi L, Fahey GC, Jr, Klurfeld DM. Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am J Clin Nutr. 2013;98:594–619. doi: 10.3945/ajcn.113.067629. [DOI] [PubMed] [Google Scholar]
  • 11.Qi L, Meigs JB, Liu S, Manson JE, Mantzoros C, Hu FB. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care. 2006;29:1501–1505. doi: 10.2337/dc06-0221. [DOI] [PubMed] [Google Scholar]
  • 12.He M, van Dam RM, Rimm E, Hu FB, Qi L. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease–specific mortality among women with type 2 diabetes mellitus. Circulation. 2010;121:2162–2168. doi: 10.1161/CIRCULATIONAHA.109.907360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Liu S, Sesso HD, Manson JE, Willett WC, Buring JE. Is intake of breakfast cereals related to total and cause-specific mortality in men? Am J Clin Nutr. 2003;77:594–599. doi: 10.1093/ajcn/77.3.594. [DOI] [PubMed] [Google Scholar]
  • 14.Lacey JV, Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health–AARP Diet and Health Study cohort. J Natl Cancer Inst. 2006;98:1397–1405. doi: 10.1093/jnci/djj375. [DOI] [PubMed] [Google Scholar]
  • 15.National Cancer Institute. Division of Cancer Control and Population Sciences: Diet history questionnaire. Accessed at: http://www.riskfactor.cancer.gov/DHQ.
  • 16.Tippett KCY. Continuing survey of food intakes by individuals, nationwide food surveys. Washington, DC: US Department of Agriculture, Agricultural Research Service; 1997. Design and operation: the continuing survey of food intakes by individuals and diet and health knowledge survey, 1994–1996. [Google Scholar]
  • 17.Prosky L, Asp NG, Furda I, DeVries JW, Schweizer TF, Harland BF. Determination of total dietary fiber in foods and food products: collaborative study. J Assoc Off Anal Chem. 1985;68:677–679. [PubMed] [Google Scholar]
  • 18.Thompson FE, Kipnis V, Midthune D, Freedman LS, Carroll RJ, Subar AF, Brown CC, Butcher MS, Mouw T, Leitzmann M, Schatzkin A. Performance of a food-frequency questionnaire in the us NIH–AARP (National Institutes of Health–American Association of Retired Persons) Diet and Health Study. Public Health Nutr. 2008;11:183–195. doi: 10.1017/S1368980007000419. [DOI] [PubMed] [Google Scholar]
  • 19.Willett W. Nutritional Epidemiology. New York: Oxford University Press; 1998. [Google Scholar]
  • 20.Park Y, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH–AARP Diet and Health Study. Arch Intern Med. 2011;171:1061–1068. doi: 10.1001/archinternmed.2011.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Maki KC, Beiseigel JM, Jonnalagadda SS, Gugger CK, Reeves MS, Farmer MV, Kaden VN, Rains TM. Whole-grain ready-toeat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods. J Am Diet Assoc. 2010;110:205–214. doi: 10.1016/j.jada.2009.10.037. [DOI] [PubMed] [Google Scholar]
  • 22.Albertson AM, Anderson GH, Crockett SJ, Goebel MT. Ready-to-eat cereal consumption: its relationship with BMI and nutrient intake of children aged 4 to 12 years. J Am Diet Assoc. 2003;103:1613–1619. doi: 10.1016/j.jada.2003.09.020. [DOI] [PubMed] [Google Scholar]
  • 23.Nicklas TA, O’Neil CE, Berenson GS. Nutrient contribution of breakfast, secular trends, and the role of ready-to-eat cereals: a review of data from the Bogalusa Heart Study. Am J Clin Nutr 1998. 1998;67:757S–763S. doi: 10.1093/ajcn/67.4.757S. [DOI] [PubMed] [Google Scholar]
  • 24.Wolever TM, Campbell JE, Geleva D, Anderson GH. High-fiber cereal reduces postprandial insulin responses in hyperinsulinemic but not normoinsulinemic subjects. Diabetes Care. 2004;27:1281–1285. doi: 10.2337/diacare.27.6.1281. [DOI] [PubMed] [Google Scholar]
  • 25.Cho S, Dietrich M, Brown CJ, Clark CA, Block G. The effect of breakfast type on total daily energy intake and body mass index: results from the third National Health and Nutrition Examination Survey (NHANES III) J Am Coll Nutr. 2003;22:296–302. doi: 10.1080/07315724.2003.10719307. [DOI] [PubMed] [Google Scholar]

RESOURCES